This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by De Conno, F. Articles by Brunelli, C. Search for Related Content PubMed PubMed Citation Articles by De Conno, F. Articles by Brunelli, C. Social Bookmarking                         What's this?

Opioid purchases and expenditure in nine western European countries: ‘Are we killing off morphine?’

Carla Ripamonti

Cinzia Brunelli

Rehabilitation and Palliative Care Operative Unit, National Cancer Institute of Milano, Milan

Background: In clinical practice the major role of opioid drugs is the management of malignant and nonmalignant pain. The primary aim of this study is to evaluate the trend in sales of four opioid analgesic drugs (codeine, tramadol, morphine, fentanyl), from wholesalers to community pharmacies, as an indicator of opioid consumption in nine European countries in 2001, 2002 and 2003. Secondary aims are to compare: (a) the amount of each drug purchased by different countries in 2003; (b) the average price for each drug in the different countries in 2003; and (c) the total expenditure for each opioid from 2001 to 2003. Methods: Data from the Statistical Report on drugs purchased by pharmacies was supplied by IMS Health, an internationally accepted information provider for the pharmaceutical and health care industries. Finding: In the period 2001-2003, while the percentage increase of purchases of fentanyl and tramadol was considerable, that of morphine was the lowest in most of the nine countries. The largest consumer of codeine was the UK and of tramadol was Belgium. The consumption of morphine was the lowest reported in all the countries together and was three times lower than that of transdermal fentanyl. There was a high variability in the costs of the opioids among the different countries. In 2003, the total expenditure on fentanyl reached the total expenditure on tramadol, followed by codeine. Morphine presents the lowest expenditure in all nine countries and over all three years. Interpretation: These results open up many questions. What factors influence opioid purchasing and costs in these European countries? It would be interesting to have the answers from those people who know the actual situation in the individual countries.

Key Words: codeine • European countries • fentanyl • morphine • opioid expenditure • opioid purchases • tramadol

Palliative Medicine, Vol. 19, No. 3, 179-184 (2005)
DOI: 10.1191/0269216305pm1002oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				E. Bandieri, A. Chiarolanza, M. Luppi, N. Magrini, A. M. Marata, and C. Ripamonti Prescription of opioids in Italy: everything, but the morphine Ann. Onc., May 1, 2009; 20(5): 961 - 962. [Full Text] [PDF]

				F De Conno, C Ripamonti, E Fagnoni, C Brunelli, M Luzzani, M Maltoni, E Arcuri, O Bertetto, and on behalf of MERITO Study Group The MERITO Study: a multicentre trial of the analgesic effect and tolerability of normal-release oral morphine during 'titration phase' in patients with cancer pain Palliative Medicine, April 1, 2008; 22(3): 214 - 221. [Abstract] [PDF]

				E. D Bruera and L. De Lima Opioid cost: a global problem Palliative Medicine, September 1, 2005; 19(6): 504 - 504. [PDF]

				O. Dale, P. Klepstad, and S. Kaasa The European Union-not united in opioid use Palliative Medicine, April 1, 2005; 19(3): 177 - 178. [PDF]